SVB’s Megan Scheffel on Bio-Hope, the 2026 Landscape, and Longevity

About this episode

Megan Scheffel discusses the current state of healthcare investment and the convergence of longevity and consumer wellness.

Join us from San Francisco, as we sit down with Megan Scheffel, Head of Healthcare and Life Science at SVB. Megan breaks down the current state of healthcare investment, moving beyond the noise to focus on deal-making quality. We cover the rising bar for entrepreneurs, the convergence of longevity and consumer wellness, and AI's impact on patient data. Don't forget to subscribe to our Substack: https://substack.com/@digitalhealthroundtable

People in this episode

Host: Matt Cybulsky PhD

Guest: Megan Scheffel

Topics covered

• healthcare investment
• longevity
• consumer wellness
• AI in healthcare
• deal-making

Keywords

• healthcare
• investment
• longevity
• AI
• patient data
• entrepreneurs

Mentioned in this episode

Organizations: SVB

Places: San Francisco

More episodes of The Digital Health Roundtable

• Uber Health at Scale with Allison Marsh · June 4, 2026 · 15 min
• Jonas Béal on Owkin Product Strategy :: AI's Role in Cancer Treatment · April 20, 2026 · 15 min
• Untangling the Data Maze:: Evidently's Vision with Kalie Dove-Maguire MD · April 9, 2026 · 22 min
• Siemens' Peter Shen on Varian's Role in Cancer Care, AI, and Precision Therapy · March 31, 2026 · 24 min
• Healthcare's Future with Philips: Shez Partovi MD, AI, and Integrated Diagnostics at HIMSS · March 20, 2026 · 8 min
• Tectonic Shifts in 2026 with Shez Partovi of Philips · January 16, 2026 · 16 min